Jay Venkatesan

(Dr. Jay Venkatesan M.D.)

Currently holds positions in Alpine Immune Sciences Inc and Exicure Inc

Positions

Position Company Period
Director Alpine Immune Sciences Inc Aug. 1, 2018 -
Independent Director Exicure Inc March 1, 2014 -
President, Director Alpine Immune Sciences Inc July 24, 2017 - Aug. 1, 2018
Executive Vice President, General Manager Cascadian Therapeutics Inc Aug. 1, 2014 - Jan. 1, 2015
Jay Venkatesan's trades of Angion Biomedica Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-27 2022-05-25
B Purchase
11,313 +0.6%
1.25
USD 14,103 		11,313 +0.6% 1.25 USD 14,103
2022-05-25 2022-05-24
B Purchase
32,200 +1.9%
1.24
USD 39,928 		32,200 +1.9% 1.24 USD 39,928
2022-05-25 2022-05-20
B Purchase
50,000 +3.1%
1.23
USD 61,500 		50,000 +3.1% 1.23 USD 61,500
2021-12-22 2021-12-20
B Purchase
3,527 +0.3%
2.54
USD 8,976 		3,527 +0.3% 2.54 USD 8,976
2021-12-20 2021-12-17
B Purchase
13,742 +1.0%
2.54
USD 34,958 		13,742 +1.0% 2.54 USD 34,958
2021-12-20 2021-12-16
B Purchase
27,883 +2.1%
2.55
USD 70,993 		27,883 +2.1% 2.55 USD 70,993
2021-12-17 2021-12-15
B Purchase
77,604 +6.3%
2.41
USD 186,956 		77,604 +6.3% 2.41 USD 186,956
2021-02-11 2021-02-09
S Sale
159,177 -11.6%
16.00
USD 2,546,832 		159,177 -11.6% 16.00 USD 2,546,832
2019-08-06 2019-08-02
US Exicure Inc (XCUR)
B Purchase
250,000 +478.6%
2.00
USD 500,000 		250,000 +478.6% 2.00 USD 500,000
2019-01-22 2019-01-18
B Purchase
190,875 +5.0%
5.37
USD 1,024,999 		190,875 +5.0% 5.37 USD 1,024,999
2017-09-28 2017-09-26
US Exicure Inc (XCUR)
B Purchase
66,666 +73.9%
3.00
USD 199,998 		66,666 +73.9% 3.00 USD 199,998
// ... existing code ... // ... rest of the file ...